Cargando…
Triple Cross-Linked Hyaluronic Acid Based on Tri-Hyal Technique Has More Durable Effect on Dermal Renewal
BACKGROUND: Hyaluronic acid (HA)-based fillers are applied to treat facial wrinkles and volume loss. Many efforts have been made to improve properties of HA to prolong the duration in aesthetic indications. A new cross-linking technique called “Tri-Hyal”, could make HAs to achieve desired rheologica...
Autores principales: | Chen, Rong, Yang, Wenbin, Sun, Jing, Liu, Yuan, An, Qing, Zhang, Feijuan, Bai, Zhuanli, Luan, Qi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9017695/ https://www.ncbi.nlm.nih.gov/pubmed/35450398 http://dx.doi.org/10.2147/CCID.S362785 |
Ejemplares similares
-
Objective 18-month Comparison of the Tolerability of 2 Dermal Fillers Formulated with Tri-Hyal Technology
por: Trevidic, Patrick, et al.
Publicado: (2020) -
HYAL1 and HYAL2 Inhibit Tumour Growth In Vivo but Not In Vitro
por: Wang, Fuli, et al.
Publicado: (2008) -
A prospective multicenter clinical trial evaluating the efficacy and safety of a hyaluronic acid‐based filler with Tri‐Hyal technology in the treatment of lips and the perioral area
por: Ehlinger‐David, Agnès, et al.
Publicado: (2022) -
Expression of Hyaluronan Synthases (HAS1–3) and Hyaluronidases (HYAL1–2) in Serous Ovarian Carcinomas: Inverse Correlation between HYAL1 and Hyaluronan Content
por: Nykopp, Timo K, et al.
Publicado: (2009) -
Comparative clinical study for the efficacy and safety of two different hyaluronic acid‐based fillers with Tri‐Hyal versus Vycross technology: A long‐term prospective randomized clinical trial
por: Braccini, Frederic, et al.
Publicado: (2022)